Vietnam Diabetes Care Devices Market: Trends, Forecast And Insights 20252033

(MENAFN- IMARC Group) The Vietnam diabetes care devices market reached a value of USD 136.8 Million in 2024 and is expected to hit USD 160.8 Million by 2033 , growing at a CAGR of 1.80% during 2025–2033. The market is being propelled by a combination of rising diabetes prevalence , government health campaigns , technological innovation , and enhanced access to healthcare facilities.

Key Highlights

• Market Size (2024): USD 136.8 Million
• Forecast (2033): USD 160.8 Million
• CAGR (2025–2033): 1.80%
• Major Drivers:
  • Rising diabetes incidence, especially Type 2
  • Government-led awareness and early screening programs
  • Technological advancements in continuous glucose monitoring (CGM)
  • Growing healthcare investments across rural and urban regions

How Technology is Advancing Diabetes Management in Vietnam

The market is witnessing a shift towards digital and minimally invasive solutions :

• Continuous Glucose Monitoring (CGM) for real-time insights and alerts
• Smart insulin pens and pumps with dose calculators and Bluetooth sync
• AI-integrated mobile apps supporting personalized diabetes management
• Telemedicine for remote diagnostics and follow-up care

Market Trends and Key Drivers

• Vietnam is experiencing a surge in diabetes cases due to urban lifestyle transitions , dietary changes , and sedentary behaviors , especially in Tier 1 and Tier 2 cities.
• Public health campaigns like “Vietnam Health Program” promote screening, early detection , and access to essential devices like glucometers and test strips.
• Expansion of local pharmaceutical manufacturing and partnerships with global diabetes device makers are enhancing product availability and affordability.
• International players and local companies are investing in smart health clinics , e-pharmacies , and medical device retail chains across Vietnam.

Request Sample For PDF Report: https://www.imarcgroup.com/vietnam-diabetes-care-devices-market/requestsample

Industry Segmentation

Device Type

• Blood Glucose Monitoring Devices
  • Self-Monitoring Devices
  • Continuous Glucose Monitoring Devices
• Insulin Delivery Devices
  • Insulin Pens
  • Insulin Pumps
  • Insulin Syringes
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Latest Developments in the Industry

• March 2025: Vietnam's Ministry of Health launched a nationwide diabetes care awareness campaign focusing on device accessibility in rural provinces.
• May 2025: Medtronic and a leading Vietnamese hospital collaborated to introduce a telehealth-enabled insulin pump program to improve remote patient outcomes.
• June 2025: The Vietnam Medical Device Expo 2025 featured over 150 exhibitors, with innovations in CGM sensors , non-invasive glucose meters , and AI-powered diabetes platforms .

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales[@]imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302

MENAFN06082025004122016232ID1109891354